The Development of Small Molecule Angiotensin IV Analogs to Treat Alzheimers and Parkinsons Diseases
Eriksson PS, Perfilieva E, Bjrk-Eriksson T, Alborn AM, Nordborg C, Peterson DA, et al
We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article
[2] Possible Medical Application BPC 157 shows strong promise as a potential treatment for a wide range of medical conditions, particularly those involving soft tissue injuries, inflammation, and even some central nervous system disorders
Two of these transcription factors, NF-B and AP-1, are involved in inflammation, cellular proliferation, and apoptosis (Silva-Adaya et al., 2014
They never serve the same payer for the same clinical purpose